294:, relative survival (as opposed to overall survival and associated with excess hazard rates) is defined as the ratio of observed survival in a population to the expected or background survival rate. It can be thought of as the kaplan-meier survivor function for a particular year, divided by the expected survival rate in that particular year. That is typically known as the
313:
There are several software suites available to estimate relative survival rates. Regression modelling can be performed using maximum likelihood estimation methods by using Stata or R. For example, the R package cmprsk may be used for competing risk analyses which utilize sub-distribution or 'Fine and
58:
This form of analysis is known by its use of death certificates. In traditional overall survival analysis, the cause of death is irrelevant to the analysis. In a competing risks survival analyses, each death certificate is reviewed. If the disease of interest is cancer, and the patient dies of a car
49:
methods is that the estimates include two causes of death: deaths from the disease of interest and deaths from all other causes, which includes old age, other cancers, trauma and any other possible cause of death. In general, survival analysis is interested in the deaths by a disease rather than all
273:
The diagnosis of cause-of-death is varied between practitioners. How does one code for a patient who dies of heart failure after receiving a chemotherapeutic agent with known deleterious cardiac side-effects? In essence, what really matters is not why the population dies but if the rate of death is
260:
The equation does not define a survival proportion but simply describes the relationships between disease-specific death (excess hazard) rates, background mortality rates (expected death rate) and the overall observed mortality rates. The excess hazard rate is related to relative survival, just as
71:
The relative survival form of analysis is more complex than "competing risks" but is considered the gold-standard for performing a cause-specific survival analysis. It is based on two rates: the overall hazard rate observed in a diseased population and the background or expected hazard rate in the
62:
For example, there is variability in the way a patient who has cancer and commits suicide is coded/labelled. In addition, if a patient has an eye removed from an ocular cancer and dies getting hit while crossing the road because he did not see the car, he would often be considered to be censored
281:
If the coding was accurate, this figure should approximate 1.0 as the rate of those dying of non-cancer deaths (in a population of cancer sufferers) should approximate that of the general population. Thus, the use of relative survival provides an accurate way to measure survival rates that are
277:
If all patients are dying of car crashes, perhaps the tumour or treatment predisposes them to have visual or perceptual disturbances, which lead them to be more likely to die in a car crash. In addition, it has been shown that patients coded in a large US cancer registry as suffering from a
75:
Deaths from the disease in a single time period are the total number of deaths (overall number of deaths) minus the expected number of deaths in the general population. If 10 deaths per hundred population occur in a population of cancer patients, but only 1 death occurs per hundred general
256:
34:, is calculated by dividing the overall survival after diagnosis by the survival as observed in a similar population not diagnosed with that disease. A similar population is composed of individuals with at least age and gender similar to those diagnosed with the disease.
269:
Relative survival is typically used in the analysis of cancer registry data. Cause-specific survival estimation using the coding of death certificates has considerable inaccuracy and inconsistency and does not permit the comparison of rates across registries.
50:
causes. Thus, a "cause-specific survival analysis" is employed to measure disease-specific survival. Thus, there are two ways in performing a cause-specific survival analysis "competing risks survival analysis" and "relative survival."
192:
59:
accident, the patient is labelled as censored at death instead of being labelled as having died. Issues with this method arise, as each hospital and or registry may code for causes of death differently.
157:
348:
Gamel, JW (2001). "Non-parametric comparison of relative versus cause-specific survival in
Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients".
41:
is used, and it presents estimates of the proportion of people or patients alive at a certain point in time. The problem with measuring overall survival by using the
305:(CRS). It is analogous to the five-year overall survival rate, but it is a way of describing cancer-specific risk of death over five years after diagnosis.
251:{\displaystyle \lambda ={\text{Overall Death Rate}},~\lambda ^{*}={\text{Expected death rate}},~\nu ={\text{Disease-specific death rate}}}
555:
121:
328:
550:
46:
472:
373:
37:
When describing the survival experience of a group of people or patients typically the method of
447:
Dickman PW, Sloggett A, Hills M, Hakulinen T (2004). "Regression models for relative survival".
278:
non-cancer death are 1.37 times as likely to die than does a member of the general population.
513:
464:
408:
365:
31:
503:
456:
400:
357:
38:
530:
Gray, Bob. "cmprsk: Subdistribution
Analysis of Competing Risks. R package version 2.2-1."
426:
492:"Estimating and modeling the cure fraction in population-based cancer survival analysis"
544:
323:
508:
491:
476:
377:
291:
42:
301:
If five consecutive years are multiplied, the resulting figure would be known as
361:
17:
404:
517:
468:
369:
412:
460:
391:
Brown, BW (1993). "Noncancer deaths in white adult cancer patients".
80:) is 9 deaths per hundred population. The classic equation for the
63:
rather than having died from the cancer or its subsequent effects.
490:
Lambert PC, Thompson JR, Weston CL, Dickman PW (2007).
195:
124:
76:
population, the disease specific number of deaths (
250:
151:
148:
531:
261:hazard rates are related to overall survival.
152:{\displaystyle \lambda =\lambda ^{*}+\nu \,\!}
8:
274:higher than that of the general population.
507:
243:
226:
217:
202:
194:
147:
135:
123:
534:. R-project. org/package= cmprsk (2010).
393:Journal of the National Cancer Institute
282:associated with the cancer in question.
350:Statistical Methods in Medical Research
340:
7:
72:general or background population.
25:
54:Competing risks survival analysis
1:
427:"Measures of Cancer Survival"
509:10.1093/biostatistics/kxl030
303:cumulative relative survival
245:Disease-specific death rate
572:
362:10.1177/096228020101000503
314:Gray' regression methods.
329:Five-year survival rate
405:10.1093/jnci/85.12.979
252:
153:
253:
154:
193:
122:
228:Expected death rate
556:Medical statistics
248:
204:Overall Death Rate
149:
82:excess hazard rate
78:excess hazard rate
47:actuarial survival
296:relative survival
246:
236:
229:
212:
205:
32:survival analysis
30:of a disease, in
28:Relative survival
16:(Redirected from
563:
535:
528:
522:
521:
511:
487:
481:
480:
461:10.1002/sim.1597
444:
438:
437:
435:
433:
423:
417:
416:
388:
382:
381:
345:
257:
255:
254:
249:
247:
244:
234:
230:
227:
222:
221:
210:
206:
203:
158:
156:
155:
150:
140:
139:
39:overall survival
21:
571:
570:
566:
565:
564:
562:
561:
560:
541:
540:
539:
538:
529:
525:
489:
488:
484:
446:
445:
441:
431:
429:
425:
424:
420:
399:(12): 979–987.
390:
389:
385:
347:
346:
342:
337:
320:
311:
288:
267:
265:Cancer survival
213:
191:
190:
131:
120:
119:
87:
84:is as follows:
69:
56:
23:
22:
18:Competing risks
15:
12:
11:
5:
569:
567:
559:
558:
553:
543:
542:
537:
536:
523:
482:
439:
418:
383:
356:(5): 339–352.
339:
338:
336:
333:
332:
331:
326:
319:
316:
310:
307:
287:
284:
266:
263:
242:
239:
233:
225:
220:
216:
209:
201:
198:
188:
187:
186:
185:
184:
183:
182:
181:
180:
179:
178:
177:
176:
175:
174:
173:
172:
171:
170:
169:
168:
167:
166:
165:
164:
163:
162:
161:
160:
159:
146:
143:
138:
134:
130:
127:
68:
65:
55:
52:
24:
14:
13:
10:
9:
6:
4:
3:
2:
568:
557:
554:
552:
549:
548:
546:
533:
527:
524:
519:
515:
510:
505:
502:(3): 576–94.
501:
497:
496:Biostatistics
493:
486:
483:
478:
474:
470:
466:
462:
458:
454:
450:
443:
440:
428:
422:
419:
414:
410:
406:
402:
398:
394:
387:
384:
379:
375:
371:
367:
363:
359:
355:
351:
344:
341:
334:
330:
327:
325:
324:Survival rate
322:
321:
317:
315:
308:
306:
304:
299:
297:
293:
285:
283:
279:
275:
271:
264:
262:
258:
240:
237:
231:
223:
218:
214:
207:
199:
196:
144:
141:
136:
132:
128:
125:
118:
117:
116:
115:
114:
113:
112:
111:
110:
109:
108:
107:
106:
105:
104:
103:
102:
101:
100:
99:
98:
97:
96:
95:
94:
93:
92:
91:
90:
89:
88:
85:
83:
79:
73:
66:
64:
60:
53:
51:
48:
44:
40:
35:
33:
29:
19:
551:Epidemiology
526:
499:
495:
485:
455:(1): 51–64.
452:
448:
442:
432:November 24,
430:. Retrieved
421:
396:
392:
386:
353:
349:
343:
312:
302:
300:
295:
292:epidemiology
289:
286:Epidemiology
280:
276:
272:
268:
259:
189:
86:
81:
77:
74:
70:
61:
57:
43:Kaplan-Meier
36:
27:
26:
532:http://CRAN
67:Hazard rate
545:Categories
335:References
238:ν
219:∗
215:λ
197:λ
145:ν
137:∗
133:λ
126:λ
518:17021277
469:14695639
449:Stat Med
370:11697226
318:See also
309:Software
477:9577626
413:8496983
378:6646370
516:
475:
467:
411:
376:
368:
298:(RS).
235:
211:
473:S2CID
374:S2CID
514:PMID
465:PMID
434:2010
409:PMID
366:PMID
504:doi
457:doi
401:doi
358:doi
290:In
45:or
547::
512:.
498:.
494:.
471:.
463:.
453:23
451:.
407:.
397:85
395:.
372:.
364:.
354:10
352:.
520:.
506::
500:8
479:.
459::
436:.
415:.
403::
380:.
360::
241:=
232:,
224:=
208:,
200:=
142:+
129:=
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.